Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Xeris Biopharma Holdings, Inc. Common Stock (XERS)

Pharmaceutical Preparations

https://www.xerispharma.com

Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome.

1375 WEST FULTON STREET, SUITE 1300
CHICAGO, IL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/21/2018

Market Cap

398,572,325

Shares Outstanding

138,130,000

Weighted SO

138,124,595

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

PLX --.--%

MCRB --.--%

CDTX --.--%

IBRX --.--%

GRTX --.--%

MREO --.--%

TERN --.--%

PDSB --.--%

INZY --.--%

Beta

1.2980

Last Div

0.0000

Range

1.46-3.26

Chg

0.0550

Avg Vol

1425059

Mkt Cap

398572325

Exch

NASDAQ

Country

US

Phone

844 445 5704

DCF Diff

2.2691

DCF

-0.0191

Div Yield

0.0000

P/S

2.1970

EV Multiple

-22.1624

P/FV

-20.5758

Div Yield %

0.0000

P/E

-6.6622

PEG

-0.1865

Payout

0.0000

Current Ratio

2.2565

Quick Ratio

1.6872

Cash Ratio

0.7631

DSO

85.3886

DIO

416.4880

Op Cycle

501.8766

DPO

56.1881

CCC

445.6885

Gross Margin

0.7924

Op Margin

-0.2050

Pretax Margin

-0.3257

Net Margin

-0.3283

Eff Tax Rate

-0.0196

ROA

-0.1796

ROE

7.5924

ROCE

-0.1451

NI/EBT

1.0082

EBT/EBIT

1.5888

EBIT/Rev

-0.2050

Debt Ratio

0.7108

D/E

-12.2259

LT Debt/Cap

1.0913

Total Debt/Cap

1.0891

Int Coverage

48.8647

CF/Debt

-0.1653

Equity Multi

-17.2007

Rec Turnover

4.2746

Pay Turnover

6.4960

Inv Turnover

0.8764

FA Turnover

6.3217

Asset Turnover

0.5469

OCF/Share

-0.2627

FCF/Share

-0.2697

Cash/Share

0.5229

OCF/Sales

-0.2148

FCF/OCF

1.0266

CF Coverage

-0.1653

ST Coverage

-7.3441

CapEx Coverage

-37.5482

Div&CapEx Cov

-37.5482

P/BV

-20.5758

P/B

-20.5758

P/S

2.1970

P/E

-6.6622

P/FCF

-9.9611

P/OCF

-10.1815

P/CF

-10.1815

PEG

-0.1865

P/S

2.1970

EV Multiple

-22.1624

P/FV

-20.5758

DPS

0.0000

Latest Headlines (EST)

PennyStocks Nov 17, 13:32 11 Top Penny Stocks To Buy Now According To Insiders PennyStocks Nov 17, 13:32 11 Top Penny Stocks To Buy Now According To Insiders PennyStocks Nov 16, 10:54 Penny Stocks to Buy? 3 To Watch With Insider Trading In November PennyStocks Nov 16, 10:54 Penny Stocks to Buy? 3 To Watch With Insider Trading In November

Revenue Product Segmentation